Verastem (VSTM) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -45.12% |
| Jun 30, 2025 | -48.19% |
| Mar 31, 2025 | -50.37% |
| Dec 31, 2024 | -46.59% |
| Sep 30, 2024 | -45.43% |
| Jun 30, 2024 | -44.56% |
| Mar 31, 2024 | -46.26% |
| Dec 31, 2023 | -55.36% |
| Sep 30, 2023 | -58.70% |
| Jun 30, 2023 | -63.02% |
| Mar 31, 2023 | -58.48% |
| Dec 31, 2022 | -54.03% |
| Sep 30, 2022 | -51.20% |
| Jun 30, 2022 | -49.16% |
| Mar 31, 2022 | -47.67% |
| Dec 31, 2021 | -46.47% |
| Sep 30, 2021 | -41.68% |
| Jun 30, 2021 | -40.32% |
| Mar 31, 2021 | -30.62% |
| Dec 31, 2020 | -21.53% |
| Sep 30, 2020 | -20.50% |
| Jun 30, 2020 | -11.13% |
| Mar 31, 2020 | -12.01% |
| Dec 31, 2019 | -12.57% |
| Sep 30, 2019 | -12.78% |
| Jun 30, 2019 | -12.72% |
| Mar 31, 2019 | -12.35% |
| Dec 31, 2018 | -12.56% |
| Sep 30, 2018 | -19.06% |
| Jun 30, 2018 | -19.74% |
| Mar 31, 2018 | -27.62% |
| Dec 31, 2017 | -32.70% |
| Sep 30, 2017 | -30.01% |
| Jun 30, 2017 | -8.87% |
| Mar 31, 2017 | 30.11% |
| Dec 31, 2016 | 30.95% |
| Sep 30, 2016 | 32.53% |
| Jun 30, 2016 | 33.27% |
| Mar 31, 2016 | 35.18% |
| Dec 31, 2015 | 36.18% |
| Sep 30, 2015 | 37.18% |
| Jun 30, 2015 | 46.44% |
| Mar 31, 2015 | 49.41% |
| Dec 31, 2014 | 58.53% |